Furthermore, recent studies suggest that utilizing human mesenchymal stem cells (hMSCs) as carriers to deliver TYMP to cancer cells may facilitate the conversion of docifluridine (5′-DFUR) into the toxic 5-FU, promoting cancer cell death (61). Here, TYMP is linked to cancer.